导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -8.38% | 3651/4773 |
| 近一周 | -2.12% | 1265/5462 |
| 近一月 | -1.06% | 854/5421 |
| 近一季 | -3.24% | 1379/5209 |
| 近半年 | -6.57% | 3107/4920 |
| 近一年 | -5.67% | 3155/4366 |
| 近两年 | 33.93% | 2128/2954 |
| 近三年 | 28.49% | 1119/2253 |
| 成立以来 | 62.48% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-8.22% 4266/4961 |
1.98% 2975/5312 |
- - |
- - |
| 2025 | 15.81% 2510/4813 |
5.14% 815/3635 |
-4.73% 3499/4076 |
14.62% 2890/4524 |
0.86% 1713/4813 |
| 2024 | 25.40% 263/3463 |
6.57% 283/2808 |
-0.61% 798/3014 |
16.94% 1305/3129 |
1.25% 1098/3463 |
| 2023 | 5.28% 193/2656 |
9.45% 405/2280 |
5.13% 71/2385 |
-4.34% 1117/2515 |
-4.35% 976/2655 |
| 2022 | -19.93% 918/2207 |
-20.68% 1564/1919 |
14.90% 186/2016 |
-10.90% 462/2113 |
-1.39% 1698/2208 |
| 2021 | -6.84% 1021/1822 |
-0.27% 347/1255 |
2.55% 997/1330 |
-14.87% 1375/1466 |
7.01% 195/1822 |
| 2020 | 35.44% 416/1250 |
-11.26% 829/1028 |
15.96% 465/1067 |
13.02% 348/1164 |
16.46% 169/1184 |
| 2019 | 43.97% 181/1092 |
31.76% 190/739 |
-0.36% 248/788 |
-3.03% 722/850 |
13.08% 30/918 |
| 2018 | -30.88% 483/834 |
- - |
-3.71% 80/631 |
-16.10% 656/660 |
-11.51% 308/682 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 广发中证全指家用电器ETF联接A VS. 长安沪深300非周期A(740101) |